The performance of multimodal hyperspectral spectroscopy in the detection of precancerous cervical lesions

Abstract

Cytology 3D structure formation based on optical microscopy images A N Pronichev, E V Polyakov, I P Shabalova et al. IntroductionCervical cancer is the second most common cancer in women worldwide [1]. In Indonesia, it is the leading cause of death among gynecological cancers.1Most patients with cervical cancer present at an advanced stage. With earlier detection, the incidence of mortality due to cervical cancer has been shown to decrease drastically. There are a number of methods to detect precancerous cervical lesions. These include visual inspections with acetic acid, cytological screening using the Papanicolaou (Pap) smear test, HPV DNA tests, and colposcopies. In many countries, the Pap test is routinely used to screen for cervical precancer. Published results, including those of a meta-analysis, showed that the sensitivity and specificity of the Pap test were 50-90% and 80-90%, respectively, whereas the sensitivity and specificity of liquid-based cytology were both 76%.2,3 The same research reported that the sensitivity and specificity of colposcopy were 70% and 44%, respectively [2,3]. The more recent HPV DNA test resulted in sensitivity and specificity of 90% and 86.5%, respectively [2,4]. Although the Pap test has been used for decades, the incidence of false negatives with this test is relatively high (10-50%) [5]. Thus, other investigations are necessary to improve its accuracy. The liquid-based cytology (e.g., ThinPrep) Pap test improves the detection of low-grade precancerous lesions. However, a clinical examination strategy for cervical cancer based on this test and follow-up colposcopies has a number of limitations, including high costs. Strategies based on new technologies need to be developed and tested to improve the detection of cervical cancer at an early

The role of Multimodal Hyperspectroscopy for Detection of Cervical Neoplasia

“…In a recent study with similar methodology, good correlation between spectroscopy and both cytology and colposcopy was noticed (79.3% , 47.9% respectively) [13] .…”

“…Multimodal spectroscopy was implemented in a cost effective new device LuViva® that can be easily operated by trained medical personnel. It is supposed to have The advantage of early detection of cervical neoplasia [13] .…”

Point‐of‐care optical devices in clinical imaging and screening: A review on the state of the art

“…To date, several studies have evaluated multimodal hyperspectral spectroscopy [66][67][68], as an optical option for detecting precancerous lesions of the cervix. The technique relies on the angular and wavelength dependence of elastically scattered light, which is used to infer the spatial frequency spectrum of a scattering object.…”